Title : Novel completed biodegradable polymer sirolimus-eluting stent versus durable polymer sirolimus-eluting stent in de novo lesions: nine-month angiographic and three-year clinical outcomes of HOPE trial.

Pub. Date : 2014

PMID : 25043067






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This study sought to evaluate the efficacy and safety of HELIOS completed biodegradable polymer sirolimus-eluting stent (SES) in de novo coronary lesions. ses IKAROS family zinc finger 2 Homo sapiens
2 CONCLUSIONS: In the HOPE trial, the novel completed biodegradable polymer SES HELIOS was non-inferior to the durable polymer SES PARTNER with respect to nine-month in-stent LLL in de novo coronary lesions. ses IKAROS family zinc finger 2 Homo sapiens